Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.855 GBX | +80.00% | -15.35% | +48.70% |
May. 31 | Graft Polymer shares up 30% as company files drug delivery patent | AN |
May. 28 | NetScientific backs Wanda; Inspirit Energy wins deal | AN |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 14.47 | 0.5986 |
Enterprise Value (EV) 1 | 12.85 | 0.4776 |
P/E ratio | -5.32 x | -0.19 x |
Yield | - | - |
Capitalization / Revenue | 26.7 x | 1.02 x |
EV / Revenue | 23.7 x | 0.81 x |
EV / EBITDA | -4.96 x | -0.21 x |
EV / FCF | -4.57 x | -0.6 x |
FCF Yield | -21.9% | -168% |
Price to Book | 3.18 x | 0.3 x |
Nbr of stocks (in thousands) | 104,097 | 104,097 |
Reference price 2 | 0.1390 | 0.005750 |
Announcement Date | 5/17/23 | 5/19/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 0.3754 | 0.542 | 0.587 |
EBITDA 1 | -1.543 | -2.593 | -2.231 |
EBIT 1 | -1.622 | -2.701 | -2.396 |
Operating Margin | -431.96% | -498.34% | -408.18% |
Earnings before Tax (EBT) 1 | -1.635 | -2.705 | -3.12 |
Net income 1 | -1.635 | -2.705 | -3.12 |
Net margin | -435.62% | -499.08% | -531.52% |
EPS 2 | -0.0234 | -0.0261 | -0.0300 |
Free Cash Flow 1 | 0.0915 | -2.81 | -0.8004 |
FCF margin | 24.37% | -518.38% | -136.35% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 6/28/22 | 5/17/23 | 5/19/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 0.36 | - | - |
Net Cash position 1 | - | 1.62 | 0.12 |
Leverage (Debt/EBITDA) | -0.2333 x | - | - |
Free Cash Flow 1 | 0.09 | -2.81 | -0.8 |
ROE (net income / shareholders' equity) | -30.6% | -101% | -94.8% |
ROA (Net income/ Total Assets) | -10.8% | -41.8% | -40.6% |
Assets 1 | 15.21 | 6.465 | 7.681 |
Book Value Per Share 2 | 0.0100 | 0.0400 | 0.0200 |
Cash Flow per Share 2 | 0.0100 | 0.0200 | 0 |
Capex 1 | 0 | 0.72 | 0.22 |
Capex / Sales | 0.46% | 132.47% | 36.8% |
Announcement Date | 6/28/22 | 5/17/23 | 5/19/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+48.70% | 758K | |
-2.83% | 19.48B | |
+2.54% | 4.12B | |
+13.42% | 1.55B | |
-5.62% | 1.22B | |
+20.12% | 967M | |
-20.61% | 617M | |
-40.94% | 525M | |
-24.96% | 253M | |
-6.04% | 251M |
- Stock Market
- Equities
- GPL Stock
- Financials Graft Polymer (UK) Plc